Therefore, after excluding BCL-2 and DLBCL subtype diagnosis (ABC vs. GCB) from the analysis, VAS was found to be independent favorable prognostic factors for PFS. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.